Overview

Gender

female

Nancy Isaac (J.D. , M.P.H.) is the Vice President of Clinical Affairs, Regulatory Affairs & Quality Neo Tract.

Nancy joined NeoTract, Inc. in January 2011 as the Vice President of Clinical Affairs, Regulatory Affairs and Quality. Nancy has over 20 years of experience in the regulated industry including basic research, regulatory affairs, quality assurance, corporate compliance and clinical research. She has worked with devices, drugs, combination products, IVDs and biologics in various therapeutic areas.

Prior to NeoTract, Nancy was Vice President of Regulatory Affairs and Quality for Neuraltus Pharmaceuticals. Before Neuraltus, Nancy was Senior Vice President of Clinical and Regulatory Affairs, and Quality Assurance for Broncus Technologies, Inc.

Before joining Broncus in 2005, she was on the operating committee and served as the VP of Regulatory and Quality for Aerogen.

When she left Becton Dickinson, she was the World Wide VP of Regulatory and Quality for BD Biosciences. She was until recently also Senior Counsel for Longwell and Associates, a Palo Alto based Food and Drug Law firm.

Nancy holds a B.S. in Cell and Molecular Biology from San Francisco State University.J.D. from Boston University School of Law with a concentration in Health Law as well as a Masters in Public Health and Law from Harvard School of Public Health.

She is a member of the California Bar.